Search Results for
“电报会员价格✅SMMFS.COM✅tg粉在线粉 在线真人粉,EXQ”
May 25, 2020
Dr. Mohit Bhandari, a member of the SAC Executive committee, a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]
November 11, 2010
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
March 16, 2022
Available Volunteer Opportunities Call for Nominations – Board of Directors After evaluating the strengths of the existing Board of Directors, the Board Development Committee is seeking individuals with the following […]
July 14, 2009
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
July 14, 2009
We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]
November 13, 2020
SAC Newsletter SAC Link The SAC Link is a quarterly newsletter for members of Osteoporosis Canada’s Scientific Advisory Council. It includes Osteoporosis Canada news, updates from committees and member news. […]
November 27, 2008
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
April 26, 2024
The release of the Osteoporosis Canada 2023 Clinical Practice Guideline will support Canadian healthcare providers in providing the most current evidence-based information for patient centred care to optimise skeletal health […]
November 4, 2021
MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]